amifostine anhydrous has been researched along with Radiation Pneumonitis in 14 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Radiation Pneumonitis: Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated the toxicity and efficacy of a Hypofractionated and intensively Accelerated RT regimen supported with amifostine Cytoprotection (HypoARC) in a cohort of 72 high-risk breast cancer patients treated with modified mastectomy or conservative surgery and FEC (5-fluorouracil/epirubicin/cyclophosphamide) chemotherapy." | 3.71 | Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients. ( Frangiadaki, C; Georgoulias, V; Giatromanolaki, A; Kakolyris, S; Koukourakis, MI; Kouroussis, C; Retalis, G; Sivridis, E, 2002) |
| "radiotherapy plus amifostine for cancer treatment." | 2.43 | Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. ( Clark, LG; Clark, OA; Sasse, AD; Sasse, EC, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (92.86) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koukourakis, MI | 2 |
| Panteliadou, M | 1 |
| Abatzoglou, IM | 1 |
| Sismanidou, K | 1 |
| Sivridis, E | 2 |
| Giatromanolaki, A | 2 |
| Antonadou, D | 4 |
| Throuvalas, N | 3 |
| Petridis, A | 2 |
| Bolanos, N | 2 |
| Sagriotis, A | 2 |
| Synodinou, M | 3 |
| Choi, NC | 1 |
| Veslemes, M | 1 |
| Komaki, R | 3 |
| Lee, JS | 2 |
| Milas, L | 3 |
| Lee, HK | 1 |
| Fossella, FV | 3 |
| Herbst, RS | 1 |
| Allen, PK | 2 |
| Liao, Z | 3 |
| Stevens, CW | 2 |
| Lu, C | 1 |
| Zinner, RG | 1 |
| Papadimitrakopoulou, VA | 1 |
| Kies, MS | 1 |
| Blumenschein, GR | 1 |
| Pisters, KM | 1 |
| Glisson, BS | 1 |
| Kurie, J | 2 |
| Kaplan, B | 2 |
| Garza, VP | 1 |
| Mooring, D | 1 |
| Tucker, SL | 1 |
| Cox, JD | 2 |
| Mehta, V | 2 |
| Gopal, R | 1 |
| Chang, JY | 1 |
| Wu, X | 1 |
| Travis, E | 1 |
| Spitz, MR | 1 |
| Wynn, RB | 1 |
| Sasse, AD | 1 |
| Clark, LG | 1 |
| Sasse, EC | 1 |
| Clark, OA | 1 |
| Coliarakis, N | 1 |
| Athanassiou, H | 1 |
| Kouveli, A | 1 |
| Verigos, C | 1 |
| Georgakopoulos, G | 1 |
| Panoussaki, K | 1 |
| Karageorgis, P | 1 |
| Kouroussis, C | 1 |
| Kakolyris, S | 1 |
| Frangiadaki, C | 1 |
| Retalis, G | 1 |
| Georgoulias, V | 1 |
| Allen, P | 1 |
| Kelly, JF | 1 |
| Zinner, R | 1 |
| Papadimitrakopoulou, V | 1 |
| Khuri, F | 1 |
| Glisson, B | 1 |
| Pisters, K | 1 |
| Herbst, R | 1 |
| Ro, J | 1 |
| Thames, HD | 1 |
| Hong, WK | 1 |
4 reviews available for amifostine anhydrous and Radiation Pneumonitis
| Article | Year |
|---|---|
Radioprotective effect of amifostine in radiation pneumonitis.
Topics: Amifostine; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic | 2003 |
Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.
Topics: Amifostine; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; | 2004 |
Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategies.
Topics: Amifostine; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combine | 2005 |
Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis.
Topics: Amifostine; Cystitis; Deglutition Disorders; Esophagitis; Humans; Neoplasms; Radiation Injuries; Rad | 2006 |
8 trials available for amifostine anhydrous and Radiation Pneumonitis
| Article | Year |
|---|---|
Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell L | 2003 |
Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
Topics: Aged; Amifostine; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modal | 2003 |
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amifostine; Antineoplastic Combined Chemotherapy Pr | 2004 |
Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.
Topics: Amifostine; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; | 2004 |
Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-S | 2005 |
Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer.
Topics: Acute Disease; Amifostine; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Premedica | 2001 |
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.
Topics: Adult; Aged; Amifostine; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Combined | 2002 |
Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
Topics: Acute Disease; Amifostine; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality | 2002 |
3 other studies available for amifostine anhydrous and Radiation Pneumonitis
| Article | Year |
|---|---|
Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Breast Neoplasms; Case-Control Studies; Combined Modalit | 2013 |
Reduction of treatment breaks and radiation-induced esophagitis and pneumonitis using amifostine in unresectable non-small cell lung cancer patients receiving definitive concurrent chemotherapy and radiation therapy: a prospective community-based clinical
Topics: Amifostine; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topi | 2005 |
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
Topics: Adult; Aged; Alkaline Phosphatase; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Breas | 2002 |